N-[[2-fluoro-4-(5-methyl-3,4-dihydropyridin-4-yl)phenyl]methyl]-1-phenyl-N-(2,2,2-trifluoroethyl)methanesulfonamide
C22H22F4N2O2S — CID 123506811
Data last refreshed: (MolForge compound catalog, from PubChem)
About N-[[2-fluoro-4-(5-methyl-3,4-dihydropyridin-4-yl)phenyl]methyl]-1-phenyl-N-(2,2,2-trifluoroethyl)methanesulfonamide
N-[[2-fluoro-4-(5-methyl-3,4-dihydropyridin-4-yl)phenyl]methyl]-1-phenyl-N-(2,2,2-trifluoroethyl)methanesulfonamide (PubChem CID 123506811) has the molecular formula C22H22F4N2O2S and a molecular weight of 454.49 g/mol. Its IUPAC name is N-[[2-fluoro-4-(5-methyl-3,4-dihydropyridin-4-yl)phenyl]methyl]-1-phenyl-N-(2,2,2-trifluoroethyl)methanesulfonamide.
Molecular Properties
| Compound Name | N-[[2-fluoro-4-(5-methyl-3,4-dihydropyridin-4-yl)phenyl]methyl]-1-phenyl-N-(2,2,2-trifluoroethyl)methanesulfonamide |
|---|---|
| PubChem CID | 123506811 |
| Molecular Formula | C22H22F4N2O2S |
| Molecular Weight | 454.49 g/mol |
| Exact Mass | 454.13 |
| IUPAC Name | N-[[2-fluoro-4-(5-methyl-3,4-dihydropyridin-4-yl)phenyl]methyl]-1-phenyl-N-(2,2,2-trifluoroethyl)methanesulfonamide |
| SMILES | CC1=CN=CCC1c1ccc(CN(CC(F)(F)F)S(=O)(=O)Cc2ccccc2)c(F)c1 |
| InChI | InChI=1S/C22H22F4N2O2S/c1-16-12-27-10-9-20(16)18-7-8-19(21(23)11-18)13-28(15-22(24,25)26)31(29,30)14-17-5-3-2-4-6-17/h2-8,10-12,20H,9,13-15H2,1H3 |
| InChIKey | ZKBIRVKQNRRNQZ-UHFFFAOYSA-N |
| XLogP | 5.18 |
| TPSA | 49.74 Ų |
| H-Bond Donors | |
| H-Bond Acceptors | 3 |
| Rotatable Bonds | 7 |
| Heavy Atoms | 31 |
| Complexity | — |
Lipinski Rule of Five
1 violation
| Rule | Value |
|---|---|
| MW ≤ 500 | 454.49 |
| LogP ≤ 5 | 5.18 |
| H-Bond Donors ≤ 5 | 0 |
| H-Bond Acceptors ≤ 10 | 3 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 123506811 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.